Counteracting the sympathetic nervous system in essential hypertension
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: This paper will provide an up-to-date overview of the adrenergic effects of the different classes of antihypertensive drugs in uncomplicated hypertension, as well as in hypertension associated with obesity, renal failure, diabetes or congestive heart failure. RECENT FINDINGS: Animal and human studies unequivocally show that sympathetic activation characterizes the hypertensive state and participates in the development, maintenance and progression of elevated blood pressure values. Evidence has also been provided that elevated sympathetic cardiovascular influences are involved in the pathogenesis of left ventricular hypertrophy, vascular hypertrophy and atherogenesis, as well as in the occurrence of metabolic disarray (i.e. metabolic syndrome, hypercholesterolemia, hyperinsulinemia and insulin resistance), which frequently accompany the hypertensive state. Antihypertensive drugs with confirmed sympathoinhibitor effects are represented by beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers. In the case of the latter two classes of antihypertensive compounds the sympathoinhibitory effects have been shown to be associated with beneficial metabolic and cardiovascular effects, a finding that supports the use of these drugs in complicated hypertension. SUMMARY: Investigation of the adrenergic effects of antihypertensive drugs has had a significant impact on cardiovascular pharmacology and hypertension treatment. Although remarkable progress has been made on this topic in recent years, future studies aimed at assessing the sympathetic effects of combination drug treatment will be helpful in improving the clinical use of the association of two or more drugs in hypertension treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Physiological aspects of primary hypertension.
Folkow, B. (1982) · Physiological Reviews · doi:10.1152/physrev.1982.62.2.347 · Cited by 1,768
Harsch, I. A., Schahin, S. P., Radespiel-Tröger, M., Weintz, O., Jahreiß, H., Fuchs, F. S., Wiest, G. H., Hahn, E. G., Lohmann, T., Konturek, P. C., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200302-206oc · Cited by 583
Baroreflex Control of Sympathetic Nerve Activity in Essential and Secondary Hypertension
Grassi, G., Cattaneo, B. M., Seravalle, G., Lanfranchi, A., & Mancia, G. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.68 · Cited by 526
Self-citationRelation Between Cardiac Sympathetic Activity and Hypertensive Left Ventricular Hypertrophy
Schlaich, M. P., Kaye, D. M., Lambert, E., Sommerville, M., Socratous, F., & Esler, M. D. (2003) · Circulation · doi:10.1161/01.cir.0000081775.72651.b6 · Cited by 459
How to assess sympathetic activity in humans
Grassi, G., & Esler, M. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917060-00001 · Cited by 455
Self-citationAdrenergic and Reflex Abnormalities in Obesity-Related Hypertension
Grassi, G., Seravalle, G., Dell’Oro, R., Turri, C., Bolla, G. B., & Mancia, G. (2000) · Hypertension · doi:10.1161/01.hyp.36.4.538 · Cited by 305
Self-citationImpact of Type 2 Diabetes Mellitus on Sympathetic Neural Mechanisms in Hypertension
Huggett, R. J., Scott, E. M., Gilbey, S. G., Stoker, J. B., Mackintosh, A. F., & Mary, D. A. S. G. (2003) · Circulation · doi:10.1161/01.cir.0000103123.66264.fe · Cited by 305
Grassi, G., Seravalle, G., Dell'Oro, R., Trevano, F. Q., Bombelli, M., Scopelliti, F., Facchini, A., & Mancia, G. (2003) · Journal of Hypertension · doi:10.1097/00004872-200309000-00027 · Cited by 225
Self-citationSympathoneural and haemodynamic characteristics of young subjects with mild essential hypertension
Floras, J. S., & Hara, K. (1993) · Journal of Hypertension · doi:10.1097/00004872-199306000-00009 · Cited by 137
Sympathetic and reflex alterations in systo-diastolic and systolic hypertension of the elderly
Grassi, G., Seravalle, G., Bertinieri, G., Turri, C., DellʼOro, R., Stella, M. L., & Mancia, G. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018050-00012 · Cited by 99
Self-citation
Cited by
The Autonomic Nervous System and Hypertension
Mancia, G., & Grassi, G. (2014) · Circulation Research · doi:10.1161/circresaha.114.302524 · Cited by 627
Self-citationDiabetic Cardiomyopathy: The Search for a Unifying Hypothesis
Poornima, I. G., Parikh, P., & Shannon, R. P. (2006) · Circulation Research · doi:10.1161/01.res.0000207406.94146.c2 · Cited by 571
The sympathetic nervous system and the metabolic syndrome
Mancia, G., Bousquet, P., Elghozi, J. L., Esler, M., Grassi, G., Julius, S., Reid, J., & Van Zwieten, P. A. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e328048d004 · Cited by 385
Self-citationAssessment of Sympathetic Cardiovascular Drive in Human Hypertension: Achievements and Perspectives
Grassi, G. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.119883 · Cited by 342
Self-citationGrassi, G., Seravalle, G., Quarti-Trevano, F., Dell'Oro, R., Arenare, F., Spaziani, D., & Mancia, G. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.121467 · Cited by 194
Self-citation
Metadata
- Authors
- Grassi, G.
- Venue
- Current Opinion in Nephrology and Hypertension
- Published
- 2004-09
- Volume
- 13
- Issue
- 5
- Pages
- 513-519
- ISSN
- 1062-4821 (ISSN-L)
- OpenAlex
- W2071279136
- Cited by
- 90
- References
- 10
- FWCI
- 5.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Counteracting the sympathetic nervous system in essential hypertension. https://app.cochat.ai/papers/10.1097/00041552-200409000-00006
- The paper
- Grassi, G. (2004). Counteracting the sympathetic nervous system in essential hypertension. Current Opinion in Nephrology and Hypertension. https://doi.org/10.1097/00041552-200409000-00006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.